Osteoporosi and Hip Fractures: Resultas of a Prevention Cambpaign Carried out at Hospital de Clínicas, University of Buenos Aires

MASTAGLIA SR, GOLDSTEIN G, BAGUR A ,PARISIS MS, OLIVERI B, MAUTALEN C.

Buenos Aires

Congreso; XXI Reunión de la Asociación Argentina de Osteología y Metabolismo Mineral (AAOMM); 2004

Asociacón Argentina de Osteología y Metabolismo Mineral

Osteoporosis and Hip Fractures: Results of a Prevention Campaign Carried out at Hospital De Clínicas, University of Buenos Aires   Mastaglia Silvina, Goldstein Griselda, Bagur Alicia, Parisi Muriel S, Oliveri Beatriz, Mautalen Carlos. Sección Osteopatías Medicas. Hospital de Clínicas, Universidad de Buenos Aires.   Osteoporosis (OP) is the most prevalent metabolic bone disease in the Western world; however it is also the most under-diagnosed and undertreated disease. The Metabolic Bone Disease Section carried out a campaign for the prevention of OP and hip fractures. It included medical guidance, conferences on OP, informative brochures, and bone mass evaluation of a group of attendants by means of densitometry of the forearm. The participants were divided into the following groups according to age and the presence of risk factors (RF), (previous fractures, premature menopause and corticoid therapy): Group A: b50 years. Group B: 50 years; this group was subdivided into B1: women between 50 and 64 years of age and men z50 years not presenting RF for OP, and B2: women between 50 and 64 years of age and men z50 presenting RF for OP. Group C: women z65 years. A total of 1,322 people participated in the campaign, 1,305 of which were z50 years (90.9% women and 7.7% men) and 17 (1.3%) were b50 years. B1 included 364 subjects, 281 women (23.4% of total number of women) and 83 men (80.5% of total number of men). B2: included 315 attendants, 295 women (24.5% of total number of women) and 20 men (19.4% of total number of men). C: included 626 women. Five hundred and ninety three participants presented RF. Group B2: 232 women presented one RF and 63 presented more than one. Group C: 209 women presented only one RF and 71 presented more than one. Evaluation of male attendants z50 years showed that 17 presented only one RF and 1 presented more than one. Of the 593 subjects presenting RF, 156 (26%) were receiving the following treatments: 80 attendants (20.9%) received oral calcium and 33 attendants (8.6%) received calcium plus vitamin D; 43 subjects (11.2%) received antiresorptive therapy. Four hundred and thirty seven subjects presenting RF (74.0%) were not receiving any form of treatment for OP. Half the participants over the age of 65 years presented moderate to marked osteopenia. Although the data obtained during this campaign are not representative of the population at large, they are a clear indication of the population’s strong demand for knowledge about their bone health status and for an evaluation of RF predisposing to osteoporotic fractures; furthermore our data reveal that only a small portion of the population receive treatment to improve bone mass.